ALKERMES reported $-41044000 in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -30360000 2.78M
Amgen AMGN:US USD 3.04B 460M
Biogen BIIB:US USD 992.8M 82.9M
Biomarin Pharmaceutical BMRN:US USD 22.38M 42.04M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 4.66B 663M
Gilead Sciences GILD:US USD 2.7B 662M
Horizon Pharma HZNP:US USD 287.24M 42.81M
Intra Cellular Therapies ITCI:US USD -55459000 32.29M
IONIS PHARMACEUT IONS:US USD -54729000 26.4M
JAZZ PHA JAZZ:US USD 348.04M 65.49M
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Marinus Pharmaceuticals MRNS:US USD -29941000 6.73M
Minerva Neurosciences NERV:US USD -5205000 1.76M
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Otsuka Holdings 4578:JP JPY 77.06B 7.4B
Pfizer PFE:US USD 6.94B 3.94B
Revance Therapeutics RVNC:US USD -72045000 19.65M
Teva Pharmaceutical Industries TEVA:US USD 1.06B 31M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M